These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2466313)

  • 1. Oral corticosteroids and histamine releasability of basophil granulocytes.
    Zimmermann I; Bugalho de Almeida AA; Schött D; Schwabl H; Ulmer WT
    Respiration; 1988; 54(2):115-8. PubMed ID: 2466313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro and in vivo effect of corticosteroids on basophil releasability in patients with mild and severe bronchial asthma.
    Kivity S; Onn A; Agami O; Fireman E
    Clin Exp Allergy; 1997 Aug; 27(8):909-14. PubMed ID: 9291288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.
    Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW
    J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [LTB4-metabolism and histamine liberation by granulocytes in the disease pattern of cystic fibrosis (CF)].
    Saak A; Schönfeld W; König W; von der Hardt H
    Pneumologie; 1991 Nov; 45(11):913-23. PubMed ID: 1722312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bronchitis and obstructive bronchitis].
    Lode H; Höffken G; Boeckh M; Mainz D
    Verh Dtsch Ges Inn Med; 1990; 96():45-8. PubMed ID: 1709319
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
    MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
    J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma.
    Casolaro V; Spadaro G; Marone G
    Am Rev Respir Dis; 1990 Nov; 142(5):1108-11. PubMed ID: 1700653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
    Casolaro V; Spadaro G; Patella V; Marone G
    J Immunol; 1993 Nov; 151(10):5563-73. PubMed ID: 7693814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease.
    Morice AH; Morris D; Lawson-Matthew P
    Clin Pharmacol Ther; 1996 Dec; 60(6):675-8. PubMed ID: 8988070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral prednisolone and dexamethasone in horses with recurrent airway obstruction in the presence of continuous antigen exposure.
    Leclere M; Lefebvre-Lavoie J; Beauchamp G; Lavoie JP
    Equine Vet J; 2010 May; 42(4):316-21. PubMed ID: 20525049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long term experiences following switching from oral administration to corticosteroid inhalation in patients with chronic aspecific lung diseases].
    Berg WC; Steenhuis EJ; Wesseling H; de Vries K
    Ned Tijdschr Geneeskd; 1979 May; 123(19):771-8. PubMed ID: 440462
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma.
    Gaddy JN; Busse WW
    Am Rev Respir Dis; 1986 Nov; 134(5):969-74. PubMed ID: 3096179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease.
    Nishimura K; Ikeda A; Koyama H; Zhang M; Tsukino M; Hajiro T; Izumi T
    Pulm Pharmacol Ther; 2000; 13(5):225-30. PubMed ID: 11001866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of histamine release from human granulocytes by ions of the rare earth elements lanthanum and cerium.
    Gruner S; Sehrt I; Müller GM; Zwirner A; Strunk D; Sönnichsen N
    Agents Actions; 1992 Jul; 36(3-4):207-11. PubMed ID: 1382374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels.
    Meeran K; Hattersley A; Burrin J; Shiner R; Ibbertson K
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):333-6. PubMed ID: 7842187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of IgE-dependent basophil releasability in allergic patients.
    Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the basophil histamine releasability in allergic rhinitis].
    Shen JX
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(2):74-6, 123. PubMed ID: 7692903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration.
    Barth J; Damoiseaux M; Möllmann H; Brandis KH; Hochhaus G; Derendorf H
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):317-24. PubMed ID: 1428295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.